Manager × security

CapWealth Advisors, LLC CVS holdings history

Who else holds this security? →

CVS HEALTH CORP · CUSIP 126650100 · CIK 1531809

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Sep 30, 2026, CapWealth Advisors, LLC reported 344.42K CVS (shares), valued at $29.51M, or 2.23% of its reported non-derivative portfolio. Filed Oct 5, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
2.23%
Shares
344.42K
344,416
Reported value
$29.51M
USD

Shares increased 1.42%; reported value decreased 15.99%, and weight changed -0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 20262.23%344,416SEC filing ↗Filed Oct 5, 2026
Q2 20262.41%339,602SEC filing ↗Filed Jul 28, 2026
Q1 20261.74%326,034SEC filing ↗Filed May 5, 2026
Q4 20251.78%328,339SEC filing ↗Filed Feb 6, 2026Amended
Q3 20251.66%318,909SEC filing ↗Filed Feb 6, 2026Amended
Q2 20252.23%326,833SEC filing ↗Filed Jul 29, 2025
Q1 20252.66%361,854SEC filing ↗Filed Apr 30, 2025
Q4 20241.67%337,977SEC filing ↗Filed Jan 30, 2025
Q3 20242.28%332,586SEC filing ↗Filed Oct 31, 2024
Q2 20242.40%320,860SEC filing ↗Filed Aug 5, 2024
Q1 20242.88%321,226SEC filing ↗Filed May 3, 2024
Q4 20233.07%319,137SEC filing ↗Filed Jan 31, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20233.07%319,137$25.20MThe prior quarter is outside the free window. Log in for the comparison.SEC filing ↗
Filed Jan 31, 2024
Q1 20242.88%321,226$25.62MShares increased 0.65%; reported value increased 1.67%, and weight changed -0.19 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 3, 2024
Q2 20242.40%320,860$18.95MShares decreased 0.11%; reported value decreased 26.04%, and weight changed -0.48 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 5, 2024
Q3 20242.28%332,586$20.91MShares increased 3.65%; reported value increased 10.36%, and weight changed -0.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 31, 2024
Q4 20241.67%337,977$15.17MShares increased 1.62%; reported value decreased 27.45%, and weight changed -0.61 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 30, 2025
Q1 20252.66%361,854$24.52MShares increased 7.06%; reported value increased 61.59%, and weight changed +0.99 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 30, 2025
Q2 20252.23%326,833$22.54MShares decreased 9.68%; reported value decreased 8.04%, and weight changed -0.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 29, 2025
Q3 20251.66%318,909$24.04MShares decreased 2.42%; reported value increased 6.64%, and weight changed -0.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 6, 2026
Q4 20251.78%328,339$26.06MShares increased 2.96%; reported value increased 8.38%, and weight changed +0.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 6, 2026
Q1 20261.74%326,034$23.42MShares decreased 0.70%; reported value decreased 10.14%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 5, 2026
Q2 20262.41%339,602$35.13MShares increased 4.16%; reported value increased 50.04%, and weight changed +0.67 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 28, 2026
Q3 20262.23%344,416$29.51MShares increased 1.42%; reported value decreased 15.99%, and weight changed -0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 5, 2026
CapWealth Advisors, LLC · CVS HEALTH CORP

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1531809","quarter":"2026Q3","cusip":"126650100"}

akkru_institutional_holdings
{"action":"history","cik":"1531809","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.